Coexistence of mitochondrial DNA and β myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure

被引:59
|
作者
Arbustini, E
Fasani, R
Morbini, P
Diegoli, M
Grasso, M
Dal Bello, B
Marangoni, E
Banfi, P
Banchieri, N
Bellini, O
Comi, G
Narula, J
Campana, C
Gavazzi, A
Danesino, C
Viganó, M
机构
[1] Univ Pavia, Policlin San Matteo, IRCCS, Sch Med,Dept Cardiovasc Pathol & Mol Diagnost, I-27100 Pavia, Italy
[2] Univ Pavia, Sch Med, Dept Cardiol, I-27100 Pavia, Italy
[3] Univ Pavia, Sch Med, Dept Cardiac Surg, I-27100 Pavia, Italy
[4] Univ Pavia, Sch Med, Dept Human Genet, I-27100 Pavia, Italy
[5] Osped Maggiore, Dept Cardiol & Neurol, Lodi, Italy
[6] Univ Milan, IRCCS Osped, Ist Clin Neurol, Ctr Dino Ferrari, Milan, Italy
[7] Allegheny Univ Hlth Sci, Philadelphia, PA 19102 USA
关键词
beta myosin heavy chain; mitochondrial DNA; hypertrophic cardiomyopathy; oxidative phosphorylation; congestive heart failure;
D O I
10.1136/hrt.80.6.548
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To investigate the possible coexistence of mitochondrial DNA (mtDNA) mutations in patients with beta myosin heavy chain (beta MHC) Linked hypertrophic cardiomyopathy (HCM) who develop congestive heart failure. Design-Molecular analysis of beta MHC and mtDNA gene defects in patients with HCM. Setting-Cardiovascular molecular diagnostic and heart transplantation reference centre in north Italy. Patients-Four patients with HCM who underwent heart transplantation for end stage heart failure, and after pedigree analysis of 60 relatives, eight additional affected patients and 27 unaffected relatives. A total of III unrelated healthy adult volunteers served as controls. Disease controls included an additional 27 patients with HCM and 102 with dilated cardiomyopathy. Intervention-Molecular analysis of DNA from myocardial and skeletal muscle tissue and from peripheral blood specimens. Main outcome measures-Screening for mutations in beta MHC (exons 3-23) and mtDNA tRNA (n = 22) genes with denaturing gradient gel electrophoresis or single strand conformational polymorphism followed by automated DNA sequencing. Results-One proband (kindred A) (plus seven affected relatives) had arginine 249 glutamine (Arg249Gln) beta MHC and heteroplasmic mtDNA tRNAIle A4300G mutations. Another unrelated patient (kindred B) with sporadic HCM had identical mutations. The remaining two patients (kindred C), a mother and son, had a novel beta MHC mutation (lysine 450 glutamic acid) (Lys450Glu) and a heteroplasmic missense (T9957C, phenylalanine (Phe)->leucine (Leu)) mtDNA mutation in subunit III of the cytochrome C oxidase gene. The amount of mutant mtDNA was higher in the myocardium than in skeletal muscle or peripheral blood and in affected patients than in asymptomatic relatives. Mutations were absent in the controls. Pathological and biochemical characteristics of patients with mutations Arg249Gln plus A4300G (kindreds A and B) were identical, but different from those of the two patients with Lys450Glu plus T9957C(Phe->Leu) mutations (kindred C). Cytochrome C oxidase activity and histoenzymatic staining were severely decreased in the two patients in kindreds A and B, but were unaffected in the two in kindred C. Conclusions-beta MHC gene and mtDNA mutations may coexist in patients with HCM and end stage congestive heart failure. Although beta MHC gene mutations seem to be the true determinants of HCM, both mtDNA mutations in these patients have known prerequisites for pathogenicity. Coexistence of other genetic abnormalities in beta MHC linked HCM, such as mtDNA mutations, may contribute to variable phenotypic expression and explain the heterogeneous behaviour of HCM.
引用
收藏
页码:548 / 558
页数:11
相关论文
共 50 条
  • [1] Coexistence of mitochondrial DNA and βmyosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure (vol 80, pg 548, 1998)
    Arbustini, E
    Fasani, R
    Morbini, P
    Banfi, P
    Comi, G
    HEART, 1999, 81 (03) : 330 - 330
  • [2] Coexistence of mitochondrial DNA and of beta Myosin Heavy Chain mutations in hypertrophic cardiomyopathies with late dilating congestive evolution
    Arbustini, E
    Fasani, R
    Grasso, M
    Morbini, P
    Diegoli, M
    Dal Bello, B
    Marangoni, E
    Banchieri, N
    Campana, C
    Gavazzi, A
    Danesino, C
    Viganò, M
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 60 - 60
  • [3] Alpha-myosin heavy chain mutations associated with dilated and hypertrophic cardiomyopathy
    Carniel, E
    Sinagra, G
    Di Lenarda, A
    Taylor, MRG
    Ku, L
    Fain, PR
    Bristow, MR
    Mestroni, L
    EUROPEAN HEART JOURNAL, 2004, 25 : 554 - 555
  • [4] Mutations in the β-Myosin Heavy Chain Gene in Southern Chinese Families with Hypertrophic Cardiomyopathy
    Zheng, D. D.
    Yang, J. H.
    Tao, Q.
    Geng, M.
    Lin, J.
    Yang, X. J.
    Song, J. P.
    Li, H. X.
    Han, L. H.
    Jiang, W. P.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (03) : 810 - 820
  • [5] β-myosin heavy chain mutations in Danish patients suffering from hypertrophic cardiomyopathy
    Andersen, PS
    Larsen, LA
    Havndrup, O
    Bundgaard, H
    Kjeldsen, K
    Vuust, J
    Christiansen, M
    AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (05): : 1651 - 1651
  • [6] Mutations of the light meromyosin domain of the β-myosin heavy chain rod in hypertrophic cardiomyopathy
    Blair, E
    Redwood, C
    Oliveira, MD
    Moolman-Smook, JC
    Brink, P
    Corfield, VA
    Östman-Smith, I
    Watkins, H
    CIRCULATION RESEARCH, 2002, 90 (03) : 263 - 269
  • [7] β-myosin heavy chain gene mutations in familial hypertrophic cardiomyopathy -: The usual suspect?
    McNally, EM
    CIRCULATION RESEARCH, 2002, 90 (03) : 246 - 247
  • [8] Functional consequences of myosin heavy chain mutations implicated in familial hypertrophic cardiomyopathy
    Yamashita, H
    Lowey, S
    Trybus, KM
    BIOPHYSICAL JOURNAL, 1997, 72 (02) : THAM2 - THAM2
  • [9] Congestive heart failure in patients with hypertrophic cardiomyopathy
    Krylova, N. S.
    Poteshkina, N. G.
    Kovalevskaya, E. A.
    Pyilev, A. V.
    EUROPEAN HEART JOURNAL, 2018, 39 : 515 - 516
  • [10] Phenotype comparison of familial hypertrophic cardiomyopathy with β-myosin heavy chain gene mutation with or without mitochondrial DNA mutation
    Arai, S
    Joh-O, K
    Furutani, M
    Hayashi, J
    Imamura, S
    Nishikawa, T
    Nagao, H
    Takao, A
    Momma, K
    Matsuoka, R
    CIRCULATION, 1999, 100 (18) : 817 - 817